1
|
Allais-Bonnet A, Castille J, Pannetier M, Passet B, Elzaïat M, André M, Montazer-Torbati F, Moazami-Goudarzi K, Vilotte JL, Pailhoux E. A specific role for PRND in goat foetal Leydig cells is suggested by prion family gene expression during gonad development in goats and mice. FEBS Open Bio 2016; 6:4-15. [PMID: 27047737 PMCID: PMC4794797 DOI: 10.1002/2211-5463.12002] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2015] [Revised: 10/22/2015] [Accepted: 11/20/2015] [Indexed: 12/17/2022] Open
Abstract
Three genes of the prion protein gene family are expressed in gonads. Comparative analyses of their expression patterns in mice and goats revealed constant expression of PRNP and SPRN in both species and in both male and female gonads, but with a weaker expression of SPRN. By contrast, expression of PRND was found to be sex‐dimorphic, in agreement with its role in spermatogenesis. More importantly, our study revealed that PRND seems to be a key marker of foetal Leydig cells specifically in goats, suggesting a yet unknown role for its encoded protein Doppel during gonadal differentiation in nonrodent mammals.
Collapse
Affiliation(s)
- Aurélie Allais-Bonnet
- Biologie du Développement et Reproduction INRA, UMR 1198 Jouy-en-Josas France; ALLICE Paris France
| | - Johan Castille
- Génétique Animale et Biologie Intégrative INRA, UMR 1313 Jouy-en-Josas France
| | - Maëlle Pannetier
- Biologie du Développement et Reproduction INRA, UMR 1198 Jouy-en-Josas France
| | - Bruno Passet
- Génétique Animale et Biologie Intégrative INRA, UMR 1313 Jouy-en-Josas France
| | - Maëva Elzaïat
- Biologie du Développement et Reproduction INRA, UMR 1198 Jouy-en-Josas France
| | - Marjolaine André
- Biologie du Développement et Reproduction INRA, UMR 1198 Jouy-en-Josas France
| | | | | | - Jean-Luc Vilotte
- Génétique Animale et Biologie Intégrative INRA, UMR 1313 Jouy-en-Josas France
| | - Eric Pailhoux
- Biologie du Développement et Reproduction INRA, UMR 1198 Jouy-en-Josas France
| |
Collapse
|
2
|
Association of an indel polymorphism in the 3′UTR of the caprine SPRN gene with scrapie positivity in the central nervous system. J Gen Virol 2012; 93:1620-1623. [DOI: 10.1099/vir.0.041400-0] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
The aim of this study was to analyse the SPRN genes of goats from several scrapie outbreaks in order to detect polymorphisms and to look for association with scrapie occurrence, by an unmatched case–control study. A region of the caprine SPRN gene encompassing the entire ORF and a fragment of the 3′UTR revealed a total of 11 mutations: 10 single-nucleotide polymorphisms and one indel polymorphism. Only two non-synonymous mutations occurring at very low incidence were identified. A significant association with scrapie positivity in the central nervous system was found for an indel polymorphism (602_606insCTCCC) in the 3′UTR. Bioinformatics analyses suggest that this indel may modulate scrapie susceptibility via a microRNA-mediated post-transcriptional mechanism. This is the first study to demonstrate an association between the SPRN gene and goat scrapie. The identified indel may serve as a genetic target other than PRNP to predict disease risk in future genetics-based scrapie-control approaches in goats.
Collapse
|
3
|
Watts JC, Stöhr J, Bhardwaj S, Wille H, Oehler A, DeArmond SJ, Giles K, Prusiner SB. Protease-resistant prions selectively decrease Shadoo protein. PLoS Pathog 2011; 7:e1002382. [PMID: 22163178 PMCID: PMC3219722 DOI: 10.1371/journal.ppat.1002382] [Citation(s) in RCA: 38] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2011] [Accepted: 10/04/2011] [Indexed: 11/30/2022] Open
Abstract
The central event in prion diseases is the conformational conversion of the cellular prion protein (PrP(C)) into PrP(Sc), a partially protease-resistant and infectious conformer. However, the mechanism by which PrP(Sc) causes neuronal dysfunction remains poorly understood. Levels of Shadoo (Sho), a protein that resembles the flexibly disordered N-terminal domain of PrP(C), were found to be reduced in the brains of mice infected with the RML strain of prions [1], implying that Sho levels may reflect the presence of PrP(Sc) in the brain. To test this hypothesis, we examined levels of Sho during prion infection using a variety of experimental systems. Sho protein levels were decreased in the brains of mice, hamsters, voles, and sheep infected with different natural and experimental prion strains. Furthermore, Sho levels were decreased in the brains of prion-infected, transgenic mice overexpressing Sho and in infected neuroblastoma cells. Time-course experiments revealed that Sho levels were inversely proportional to levels of protease-resistant PrP(Sc). Membrane anchoring and the N-terminal domain of PrP both influenced the inverse relationship between Sho and PrP(Sc). Although increased Sho levels had no discernible effect on prion replication in mice, we conclude that Sho is the first non-PrP marker specific for prion disease. Additional studies using this paradigm may provide insight into the cellular pathways and systems subverted by PrP(Sc) during prion disease.
Collapse
Affiliation(s)
- Joel C. Watts
- Institute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, California, United States of America
| | - Jan Stöhr
- Institute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, California, United States of America
| | - Sumita Bhardwaj
- Institute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, California, United States of America
| | - Holger Wille
- Institute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, California, United States of America
- Department of Neurology, University of California, San Francisco, San Francisco, California, United States of America
| | - Abby Oehler
- Department of Pathology, University of California, San Francisco, San Francisco, California, United States of America
| | - Stephen J. DeArmond
- Institute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, California, United States of America
- Department of Pathology, University of California, San Francisco, San Francisco, California, United States of America
| | - Kurt Giles
- Institute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, California, United States of America
- Department of Neurology, University of California, San Francisco, San Francisco, California, United States of America
| | - Stanley B. Prusiner
- Institute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, California, United States of America
- Department of Neurology, University of California, San Francisco, San Francisco, California, United States of America
| |
Collapse
|